1/5
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Drug therapy
Involves the treatment of schizophrenia through the use of antipsychotic medication to reduce symptoms
All antipsychotics work by reducing dopamine transmission - reducing the actions of the neurotransmitter dopamine areas of the brain associated with the symptoms of schizophrenia
Types of antipsychotics
Typical
Atypical
Typical antipsychotics
Work as dopamine antagonists: reduce dopamine activity by blocking dopamine receptors at the synapse
Bind to dopamine receptors but do not stimulate them, reducing the action of dopamine
Initially dopamine levels build up, but then production is reduce
This normalises neurotransmission in key areas of the brain, reducing positive symptoms
Side effects: CHLORPROMAZINE
dry mouth
Lethargy
Tardive dyskinesia - uncontrollable muscle movements usually affecting the face
Atypical antipsychotics
Block dopamine receptors, but only temporarily occupy and then rapidly dissociate to allow normal dopamine transmission
Also act on other neurotramitters, targeting negative symptoms: serotonin and glutamate
Side effects: CLOZAPINE/RISPERIDONE
Cardiovascular problems
Arangulocytosis: fatally low levels of neutrophil
Negative evaluations (3)
Likelihood of side effects ranging from mild/serious/fatal is extremely high
Critics argue if side effects were taken into account a cost-benefit analysis of its advantages would be negative
In the USA a large out of court settlement was awarded to a tardive dyskinesia sufferer on the basis of HRA , that no one should be subject to inhumane treatment
Widely believed that antipsychotics have been used in hospital situations to make patients calmer and easier to deal with - patients with severe symptoms may not be able to give fully informed consent
Healey 2012 - argued that some results of clinical trials have had their data published multiples times in order to exaggerate the positive effects
Positive evaluations (2)
Enhance the quality of life for patients as they allow them to live independently of institutional care.
Leucht 2012 - meta-analysis of 65 studies involving 6000 patients with some taken off antipsychotics
12 months: 64% placebo relapsed VS. 27% drugs